Prostate Cancer News and Research

Latest Prostate Cancer News and Research

COVID-19 associated with higher risk of erectile dysfunction

Men previously diagnosed with COVID-19 are at a greater risk of developing new-onset erectile dysfunction.

31 May 2024

Understanding the long-term effects and safety of testosterone therapy in transgender men

Transgender individuals often face unique challenges in aligning their physical bodies with their true gender identity.

30 May 2024

MUSC researchers unravel the mystery of cancer recurrence

MUSC Hollings Cancer Center researchers have unlocked a discovery that could help to explain why cancer can recur in patients who have undergone chemotherapy or radiotherapy.

28 May 2024

Underappreciated set of enzymes connected to the regulation of hippo pathway in cancer

Within the family of cell membrane lipids known as phosphoinositides and the kinase enzymes that regulate them, phosphoinositide 3-kinases (PI3Ks) have been cast in a starring role as scientists study their involvement in cancer, diabetes and many cellular activities.

28 May 2024

Study reveals cancer treatment disparities at minority-serving hospitals

It’s important to ensure that care provided at US hospitals that predominantly serve Black and Hispanic populations is as high-quality as the care provided at other US hospitals.

27 May 2024

$Osaka University to pioneer world-first clinical trial for refractory prostate cancer with alpha-ray therapy$

Osaka University to pioneer world-first clinical trial for refractory prostate cancer with alpha-ray therapy

A research team at Osaka University will start an investigator-initiated clinical trial for refractory prostate cancer patients after the successful development of a new alpha-ray therapeutic agent ([At-211] PSMA-5) and confirmation of its efficacy in animal models.

27 May 2024

Physician-pharmacy integration not associated with change in the care of cancer patients

Integration of pharmacies with physician practices, where on-site pharmacies open at physician practice locations, is a growing trend in cancer treatment.

23 May 2024

Determinants of treatment decisions in newly diagnosed prostate cancer patients

Patients with newly diagnosed prostate cancer (PCA) face the critical decision of whether to undergo treatment with curative intent (TCI, surgery or radiation) or conservative treatment on the background of a cancer where the potential for over-treatment and under-treatment is real.

23 May 2024

Study suggests miR-377 as potential therapeutic target for prostate cancer

A new research paper was published in Genes & Cancer on May 16, 2024, entitled, "Inhibitory effect of miR-377 on the proliferative and invasive behaviors of prostate cancer cells through the modulation of MYC mRNA via its interaction with BCL-2/Bax, PTEN, and CDK4."

22 May 2024

Novel therapy reprograms immune cells, shrinks prostate and bladder cancers in animal study

A novel therapy that reprograms immune cells to promote antitumor activity helped shrink hard-to-treat prostate and bladder cancers in mice, according to research from the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy and Johns Hopkins Drug Discovery.

21 May 2024

Proteins in the blood could warn people of cancer more than seven years before it is diagnosed

Researchers from the UK investigated associations between 1,463 plasma proteins and 19 cancers, using observational and genetic approaches in participants of the UK Biobank.

17 May 2024

Plant-based diets could reduce the chances of disease progression in men with prostate cancer

Men with prostate cancer could significantly reduce the chances of the disease worsening by eating more fruits, vegetables, nuts, and olive oil, according to new research by UC San Francisco.

13 May 2024

DoD grant awarded for investigating alternative polyadenylation in prostate cancer

A team led by Dr. Eddie Imada, assistant professor of research in pathology and laboratory medicine, has been awarded a three-year, $1.5 million United States Department of Defense grant for research on a cellular process called alternative polyadenylation and its role in prostate cancer.

10 May 2024

Precision medicine in PET imaging: AI-based attenuation correction for enhanced patient care

A new research paper was published in Oncotarget's Volume 15 on May 7, 2024, entitled, "Deep learning-based whole-body PSMA PET/CT attenuation correction utilizing Pix-2-Pix GAN."

9 May 2024

Deep learning models for predicting prostate cancer recurrence risk from 3D pathology datasets

Human tissue is intricate, complex and, of course, three dimensional. But the thin slices of tissue that pathologists most often use to diagnose disease are two dimensional, offering only a limited glimpse at the tissue's true complexity.

9 May 2024

Forget ringing the button for the nurse. Patients now stay connected by wearing one.

Patients admitted to Houston Methodist Hospital get a monitoring device about the size of a half-dollar affixed to their chest — and an unwitting role in the expanding use of artificial intelligence in health care.

8 May 2024

University of Liverpool invests £1M in state-of-the-art teaching facilities for healthcare students

The University of Liverpool has invested more than £1m in new state-of-the-art teaching facilities, that are set to give healthcare students unique opportunities to learn. The Florence Nightingale and Rose Thompson Suites in the School of Allied Health Professions and Nursing are now open.

8 May 2024

Firefighters at increased risk of prostate cancer due to chemical exposures, study reveals

Firefighters may have an increased risk of prostate cancer due to on-the-job chemical exposures, according to new research from the University of Arizona Mel and Enid Zuckerman College of Public Health and University of Michigan in collaboration with fire service partners and researchers around the country through the Fire Fighter Cancer Cohort Study.

7 May 2024

Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challenge

When doctors began using the drug sotorasib in 2021 with high expectations for its innovative approach to attacking lung cancer, retired medical technician Don Crosslin was an early beneficiary.

7 May 2024

What is the association between post-diagnostic plant-based dietary patterns and the risk of prostate cancer progression?

The relationship between the risk of progression of prostate cancer and plant-based diet adherence.

6 May 2024

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

COVID-19 associated with higher risk of erectile dysfunction

Understanding the long-term effects and safety of testosterone therapy in transgender men

MUSC researchers unravel the mystery of cancer recurrence

Underappreciated set of enzymes connected to the regulation of hippo pathway in cancer

Study reveals cancer treatment disparities at minority-serving hospitals

Osaka University to pioneer world-first clinical trial for refractory prostate cancer with alpha-ray therapy

Physician-pharmacy integration not associated with change in the care of cancer patients

Determinants of treatment decisions in newly diagnosed prostate cancer patients

Study suggests miR-377 as potential therapeutic target for prostate cancer

Novel therapy reprograms immune cells, shrinks prostate and bladder cancers in animal study

Proteins in the blood could warn people of cancer more than seven years before it is diagnosed

Plant-based diets could reduce the chances of disease progression in men with prostate cancer

DoD grant awarded for investigating alternative polyadenylation in prostate cancer

Precision medicine in PET imaging: AI-based attenuation correction for enhanced patient care

Deep learning models for predicting prostate cancer recurrence risk from 3D pathology datasets

Forget ringing the button for the nurse. Patients now stay connected by wearing one.

University of Liverpool invests £1M in state-of-the-art teaching facilities for healthcare students

Firefighters at increased risk of prostate cancer due to chemical exposures, study reveals

Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challenge

What is the association between post-diagnostic plant-based dietary patterns and the risk of prostate cancer progression?

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in